QL
MDGL icon

Quarry LP’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quarry LP’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Buy
+4
New +$2.05K ﹤0.01% 1594
2026
Q1 		– Sell
-55
Closed -$32K – 1928
2025
Q4 		$32K Sell
55
-31
-36% -$15.8K 0.01% 788
2025
Q3 		$39.4K Buy
+86
New +$32.1K 0.01% 979
2025
Q2 		– Sell
-700
Closed -$232K – 1926
2025
Q1 		$232K Buy
+700
New +$230K 0.05% 277

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quarry LP's MDGL Position: Q2 2026 in Review

Quarry LP opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 4 shares worth $2.15K. The stake represents ﹤0.01% of the portfolio and ranks #1594 among its holdings. This is a return to the name: Quarry LP previously reported a position in MDGL as recently as Q4 2025.

Quarry LP first reported a position in MDGL in Q1 2025 and has held it in 4 quarters since. The position peaked at $232K in Q1 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Quarry LP held 4 shares of Madrigal Pharmaceuticals worth $2.15K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1594 holding.
  • Quarry LP first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • Quarry LP's Madrigal Pharmaceuticals position peaked at $232K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.